drugset / Trial / NCT00502775

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

NCT00502775

Phase 4 Completed 680 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of the study is to compare nighttime symptom relief of fluticasone furoate nasal spray versus oral fexofenadine

Timeline

Start
2007-08
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown Oral
Subject Fluticasone Furoate Other / unclassified Intranasal